Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3)

por Ali, Abir Salwa, Grönberg, Malin, Langer, Seppo W., Ladekarl, Morten, Hjortland, Geir Olav, Vestermark, Lene Weber, Österlund, Pia, Welin, Staffan, Grønbæk, Henning, Knigge, Ulrich, Sorbye, Halfdan, Janson, Eva Tiensuu
Publicado 2018

Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma

por Ali, Abir Salwa, Grönberg, Malin, Federspiel, Birgitte, Scoazec, Jean-Yves, Hjortland, Geir Olav, Grønbæk, Henning, Ladekarl, Morten, Langer, Seppo W., Welin, Staffan, Vestermark, Lene Weber, Arola, Johanna, Österlund, Pia, Knigge, Ulrich, Sorbye, Halfdan, Grimelius, Lars, Janson, Eva Tiensuu
Publicado 2017